News & Updates

In patients on long-term hydroxychloroquine (HCQ) therapy, rapid macular thinning appears to alert a potential retinal damage related to HCQ treatment, a study has found.

Inappropriate prescription practices and polypharmacy remain a burden in patients treated with immune checkpoint inhibitors (ICIs), a study has found.

All urate-lowering therapies work to reduce uric acid concentrations in patients with chronic kidney disease (CKD), although it is unclear whether this benefit extends to those with renal disease, according to the results of a meta-analysis.

Treatment with either high- or low-dose lebrikizumab reduces the rate of exacerbation in patients with uncontrolled asthma, according to the ACOUSTICS* trial presented at ATS 2022.

Pharmaceutical workers who serve in healthcare settings are in danger of antineoplastic drug contamination not just inside the compounding room but also in adjacent rooms, reveals a study.

The use of the oral GnRH antagonist linzagolix in patients with heavy menstrual bleeding (HMB) due to uterine fibroids induced multiple benefits including improved haemoglobin (Hb) levels, health-related quality of life (HRQoL), and mood, analysis of the PRIMROSE 1 and 2 trials showed.

The first-in-class attachment inhibitor fostemsavir, when combined with optimized background therapy (OBT), provides an important treatment option for heavily treated HIV-1 patients with multidrug resistance and limited available antiretroviral (ARV) options, a matching adjusted indirect comparison (MAIC) analysis has shown.

In paediatric patients undergoing appendectomy, an insufficient antibiotic regimen may result in longer length of stay (LOS) and more infectious complications, which validates the expansion of a simple antibiotic regimen in cases of severe intra-abdominal findings, a study has shown. In uncomplicated cases of appendicitis, treatment with ampicillin-sulbactam (AS) is suggested.